Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough.
Asian-News.net is your go-to online destination for comprehensive coverage of major news across Asia. From politics and business to culture and technology, we bring you the latest updates, deep analyses, and critical insights from every corner of the continent. Featuring exclusive interviews, high-quality photos, and engaging videos, we keep you informed on the breaking news and significant events shaping Asia. Stay connected with us to get a 24/7 update on the most important stories and trends. Our daily updates ensure that you never miss a beat on the happenings in Asia's diverse nations. Whether it's a political shift in China, economic development in India, technological advancements in Japan, or cultural events in Southeast Asia, Asian-News.net has it covered. Dive into the world of Asian news with us and stay ahead in understanding this dynamic and vibrant region.
Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough.
The U.S. Food and Drug Administration on Mondaycleared Apple's new sleep apnea detection feature for use, which means it will come to the Apple Watch Series 9, Series 10, and Ultra 2 later this month.
Pfizer's experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday.
Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business.
Experts call it "economy class syndrome" — but it can happen to anyone in any class of an airplane.
Last month, the American Red Cross declared an emergency blood shortage after its national supply fell by more than 25% in July. One startup's solution: Lab-grown blood.
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.
The health ministry says the young patient recently travelled from a country experiencing the virus outbreak.